EC Number   |
Inhibitors |
Structure |
|---|
    2.6.1.62 | (R)-8-amino-7-oxononanoate |
binds both to the pyridoxal 5'-phosphate form and to the pyridoxamine 5'-phosphate form by forming specific hydrogen bonds with residue T309 and the phosphate group of the cofactor |
   |
| 2.6.1.62 | (R)-8-amino-7-oxononanoic acid |
potent inhibitor |
|
| 2.6.1.62 | (Z)-N-(2-isopropoxyphenyl)-2-oxo-2-((3-(trifluoromethyl)cyclohexyl)amino)acetimidic acid |
83% inhibition at 0.01 mg/ml; 83% inhibition at 0.01 mg/ml |
|
| 2.6.1.62 | 1-(1,3-benzothiazol-2-yl)methanamine |
- |
|
| 2.6.1.62 | 1-[4-[2-(2,5-dimethylbenzene-1-sulfonyl)ethyl]piperazin-1-yl]-4-methylpentan-1-one |
- |
|
| 2.6.1.62 | 2-(2-acetyl-5-methoxyphenoxy)-N-(1-phenylethyl)propanamide |
- |
|
| 2.6.1.62 | 2-([2-[(5-ethyl-4-propyl-1,3-thiazol-2-yl)amino]-2-oxoethyl]sulfanyl)-N-(5-methyl-1,2-oxazol-3-yl)propanamide |
- |
|
| 2.6.1.62 | 2-hydrazinyl-1,3-benzothiazole |
reversible covalent inhibitor |
|
| 2.6.1.62 | 2-oxo-6-phenyl-N-[2-[(prop-2-en-1-yl)carbamoyl]phenyl]-1,2-dihydropyridine-3-carboxamide |
- |
|
| 2.6.1.62 | 3-(4-aminocyclopent-2-en-1-yl)propan-1-ol |
- |
|
